OSAM
MRNS

O'Shaughnessy Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Hold
0
– – – 2040
2020
Q2 		– Sell
-1
Closed -$9 – 1938
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1897
2019
Q4 		$0 Buy
+1
New +$6 ﹤0.01% 1928

Other funds holding MRNS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

O'Shaughnessy Asset Management's MRNS Position: Q3 2020 in Review

O'Shaughnessy Asset Management held its Marinus Pharmaceuticals, Inc (MRNS) position steady in Q3 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

O'Shaughnessy Asset Management first reported a position in MRNS in Q4 2019 and has held it in 2 quarters since. The position peaked at $0 in Q1 2020. 77 funds tracked by Wall St. Rank hold MRNS as of Q3 2020.

  • O'Shaughnessy Asset Management held 0 shares of Marinus Pharmaceuticals, Inc worth $0 as of Q3 2020.
  • O'Shaughnessy Asset Management left its Marinus Pharmaceuticals, Inc share count unchanged in Q3 2020.
  • Marinus Pharmaceuticals, Inc made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q3 2020, its #2040 holding.
  • O'Shaughnessy Asset Management first reported a position in Marinus Pharmaceuticals, Inc in Q4 2019 and has held it in 2 quarters since.
  • O'Shaughnessy Asset Management's Marinus Pharmaceuticals, Inc position peaked at $0 in Q1 2020.
  • 77 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2020.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.